Daniel J. Becker

Daniel J. Becker is a declared insider at 2 companies (board member); the most frequent names are ACELYRIN, Inc. and Day One Biopharmaceuticals, Inc. Over a trading history stretching from 1 June 2021 to 21 May 2025, the count stands at 4 filings.

Market trades split into 2 purchases (€115k) and 1 sale (€6). The net balance comes to €115k on the buying side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

Most recently, on 23 May 2025, the filings show a transaction in ACELYRIN, Inc. The clock since the last published purchase (11 May 2023) now reads 1,256 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.